Japan's national tuberculosis control strategies with economic considerations

Environmental Health and Preventive Medicine

Volumn 10, Issue 4, 2005, Pages 213-218

  Ghotbi, Nader ^a   Nishimura, Shuzo ^a   Takatsuka, Naoyoshi ^b  

^a KYOTO UNIVERSITY   (Japan)

^b Gifu Graduate School of Medicine   (Japan)

Author keywords

Active case finding (AFC); BCG immunization; Mass miniature radiography (MMR); Sputum smear examination; Tuberculosis (TB)

Indexed keywords

BCG VACCINE;

BCG VACCINATION; COST EFFECTIVENESS ANALYSIS; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; INCIDENCE; INFECTION CONTROL; JAPAN; MASS RADIOGRAPHY; PREVALENCE; PUBLIC HEALTH; REVIEW; SCREENING; TUBERCULOSIS; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 24944563381     PISSN: 1342078X     EISSN: None     Source Type: Journal    
DOI: 10.1265/ehpm.10.213     Document Type: Review

References (29)

1. Kistemann T, Munzinger A, Dangendorf F. Spatial patterns of tuberculosis incidence in Cologne (Germany). Soc Sci Med. 2002; 55: 7-19.
2. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991; 144: 745-749.
3. The World Health Organization (WHO). Guidelines for cost and cost-effectiveness analysis of tuberculosis control; Document 1: Introduction, important economic concepts, protocols and useful references. Geneva: World Health Organization publications; 2002.
4. Rahman M, Sekimoto M, Hira K, Koyama H, Imanaka Y, Fukui T. Is Bacillus Calmette-Guerin revaccination necessary for Japanese children? Prev Med. 2002; 35: 70-77.
5. Mori T. Recent trends in tuberculosis, Japan. Emerg Infect Dis. 2000; 6: 566-568.
6. Rahman M, Sekimoto M, Takamatsu I, Hira K, Shimbo T, Toyoshima K, Fukui T. Economic evaluation of universal BCG vaccination of Japanese infants. Int J Epidemiol. 2001;30: 380-385.
7. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature. JAMA. 1994; 271: 698-702.
8. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993; 22: 1154-1158.
9. Smith PG. Case-control studies of the efficacy of BCG against tuberculosis. In: International Union Against Tuberculosis editors. Proceedings of the XXVIth IUATLD World Conference on Tuberculosis and Respiratory Diseases. Singapore: Professional Postgraduate Services International; 1987. p.73-79.
10. The World Health Organization (WHO). Global tuberculosis program and global program on vaccines: Statement on BCG revaccination for prevention of tuberculosis. WHO Wkly Epidem Rec. 1995; 70: 229-236.
11. Leung CC, Tam CM, Chan SL, Chan MMW, Chan CK, Chang KC. Efficacy of the BCG revaccination program in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis. 2001; 5: 717-723.
12. Tam CM, Leung CC. Cessation of the BCG (bacilli Calmette Guerin): Revaccination program for primary school children in Hong Kong. Public Health & Epidemiology Bulletin. 2000;9: 25-27.
13. Ballew KA, Becker DM. Tuberculosis screening in adults who have received bacille Calmette-Guerin vaccine. South Med J. 1995; 88: 1025-1030.
14. Schwartzman K, Menzies D. Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med. 2000; 161: 780-789.
15. Lotte A, Wasz-Hockert O, Poisson N, et al. BCG complications. Adv Tuberc Res. 1984; 21; 107-193.
16. Kekkaku No Toukei (Statistics of TB). Shiryo Hyo 6 (Table 6). Kiyose/Tokyo, The Research Institute of Tuberculosis(J.A.T.A.): 2004. p. 27. (in Japanese)
17. Kekkaku No Toukei (Statistics of TB). Shiryo Hyo 13 (Table 13). Kiyose/Tokyo, The Research Institute of Tuberculosis (J.A.T.A.): 2004. p. 31. (in Japanese)
18. Ohmori M, Wada M, Uchimura K, Nishii K, Shirai Y, Aoki M. Discussing the current situation of tuberculosis case finding by mass miniature radiography in Japan. Kekkaku.2002; 77: 4329-4339.
19. Heldal E, Döcker H, Tverdal A. Previous Tuberculosis Disease or Infection in Norwegian-born Patients with Pulmonary Tuberculosis, 1975, 1985, 1995. National Health Screening Service, Ministry of Health, Oslo, Norway.
20. Pang SC. Chest radiography and tuberculosis case-finding in Western Australia. Respir Med. 1998; 92: 198-202.
21. Kimerling ME, Schuchter J, Chanthol E, Kunthy T, Stuer F, Glaziou P, Ee O. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia; Int J Tuberc Lung Dis. 2002; 6:988-994.
22. Harries AD, Kamenya A, Subramanyam VR, Maher D, Squire SB, Wirima JJ, Nyangulu DS, Nunn P. Screening pulmonary tuberculosis suspects in Malawi: testing different strategies. Trans R Soc Trop Med Hyg. 1997; 91: 416-419.
23. Aluoch JA, Edwards EA, Stott H, Fox W, Sutherland I. A fourth study of case-finding methods for pulmonary tuberculosis in Kenya. Trans R Soc Trop Med Hyg. 1982; 76: 679-691.
24. Harries AD, Mphasa NB, Mundy C, Banerjee A, Kwanjana JH, Salaniponi FM. Screening tuberculosis suspects using two sputum smears. Int J Tuberc Lung Dis. 2000; 4: 36-40.
25. Yamamura J, Sawada T. A study on patients with tuberculosis among foreigners overstayed in Japan after expiration of visa - activities over three years. Kekkaku. 2002; 77: 671-677.
26. Mallet L, Strozyk WR. Tuberculosis in the elderly: incidence, manifestations, PPD skin tests, and preventive therapy. DICP. 1991; 25: 650-655.
27. Falchook G, Gaffga C, Eve S, Ali J. Tuberculosis screening, referral, and treatment in an inner city homeless shelter in Orleans parish. J La State Med Soc. 2000; 152: 398-404.
28. Dasgupta K, Schwartzman K, Marchand R, Tennenbaum TN, Brassard P, Menzies D. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med. 2000; 162: 2079-2086.
29. Mori T. Current tuberculosis problem in Japan and its control. Intern Med. 2002; 41: 56-57.